Literature DB >> 31005224

Feasibility of stereotactic radiotherapy using a 1.5 T MR-linac: Multi-fraction treatment of pelvic lymph node oligometastases.

Anita M Werensteijn-Honingh1, Petra S Kroon2, Dennis Winkel2, Ellart M Aalbers2, Bram van Asselen2, Gijsbert H Bol2, Kevin J Brown3, Wietse S C Eppinga2, Corine A van Es2, Markus Glitzner2, Eline N de Groot-van Breugel2, Sara L Hackett2, Martijn Intven2, Jan G M Kok2, Charis Kontaxis2, Alexis N Kotte2, Jan J W Lagendijk2, Mariëlle E P Philippens2, Rob H N Tijssen2, Jochem W H Wolthaus2, Simon J Woodings2, Bas W Raaymakers2, Ina M Jürgenliemk-Schulz2.   

Abstract

Online adaptive radiotherapy using the 1.5 Tesla MR-linac is feasible for SBRT (5 × 7 Gy) of pelvic lymph node oligometastases. The workflow allows full online planning based on daily anatomy. Session duration is less than 60 min. Quality assurance tests, including independent 3D dose calculations and film measurements were passed.
Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.

Keywords:  MR-guided radiotherapy; MR-linac; Magnetic resonance imaging; Radiotherapy; Workflow

Mesh：

Year:  2019        PMID： 31005224     DOI： 10.1016/j.radonc.2019.01.024

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN： 0167-8140            Impact factor:   6.280


  43 in total

1.  Feasibility of spinal stereotactic body radiotherapy in Elekta Unity® MR-Linac.

Authors:  Eun Young Han; Manik Aima; Neil Hughes; Tina M Briere; Debra N Yeboa; Pam Castillo; Jihong Wang; Jinzhong Yang; Sastry Vedam
Journal:  J Radiosurg SBRT       Date:  2020

Review 2.  Online daily adaptive proton therapy.

Authors:  Francesca Albertini; Michael Matter; Lena Nenoff; Ye Zhang; Antony Lomax
Journal:  Br J Radiol       Date:  2019-11-11       Impact factor: 3.039

3.  Initial Feasibility and Clinical Implementation of Daily MR-Guided Adaptive Head and Neck Cancer Radiation Therapy on a 1.5T MR-Linac System: Prospective R-IDEAL 2a/2b Systematic Clinical Evaluation of Technical Innovation.

Authors:  Brigid A McDonald; Sastry Vedam; Jinzhong Yang; Jihong Wang; Pamela Castillo; Belinda Lee; Angela Sobremonte; Sara Ahmed; Yao Ding; Abdallah S R Mohamed; Peter Balter; Neil Hughes; Daniela Thorwarth; Marcel Nachbar; Marielle E P Philippens; Chris H J Terhaard; Daniel Zips; Simon Böke; Musaddiq J Awan; John Christodouleas; Clifton D Fuller
Journal:  Int J Radiat Oncol Biol Phys       Date:  2020-12-16       Impact factor: 7.038

4.  Impact of magnetic resonance-guided versus conventional radiotherapy workflows on organ at risk doses in stereotactic body radiotherapy for lymph node oligometastases.

Authors:  Anita M Werensteijn-Honingh; Petra S Kroon; Dennis Winkel; J Carlijn van Gaal; Jochem Hes; Louk M W Snoeren; Jaleesa K Timmer; Christiaan C P Mout; Gijsbert H Bol; Alexis N Kotte; Wietse S C Eppinga; Martijn Intven; Bas W Raaymakers; Ina M Jürgenliemk-Schulz
Journal:  Phys Imaging Radiat Oncol       Date:  2022-06-30

5.  Mitigation on bowel loops daily variations by 1.5-T MR-guided daily-adaptive SBRT for abdomino-pelvic lymph-nodal oligometastases.

Authors:  Francesco Cuccia; Michele Rigo; Davide Gurrera; Luca Nicosia; Rosario Mazzola; Vanessa Figlia; Niccolò Giaj-Levra; Francesco Ricchetti; Giorgio Attinà; Edoardo Pastorello; Antonio De Simone; Stefania Naccarato; Gianluisa Sicignano; Ruggero Ruggieri; Filippo Alongi
Journal:  J Cancer Res Clin Oncol       Date:  2021-07-15       Impact factor: 4.553

Review 6.  The transformation of radiation oncology using real-time magnetic resonance guidance: A review.

Authors:  William A Hall; Eric S Paulson; Uulke A van der Heide; Clifton D Fuller; B W Raaymakers; Jan J W Lagendijk; X Allen Li; David A Jaffray; Laura A Dawson; Beth Erickson; Marcel Verheij; Kevin J Harrington; Arjun Sahgal; Percy Lee; Parag J Parikh; Michael F Bassetti; Clifford G Robinson; Bruce D Minsky; Ananya Choudhury; Robert J H A Tersteeg; Christopher J Schultz
Journal:  Eur J Cancer       Date:  2019-10-12       Impact factor: 9.162

7.  Clinical Implementation and Initial Experience With a 1.5 Tesla MR-Linac for MR-Guided Radiation Therapy for Gynecologic Cancer: An R-IDEAL Stage 1 and 2a First in Humans Feasibility Study of New Technology Implementation.

Authors:  David S Lakomy; Jinzhong Yang; Sastry Vedam; Jihong Wang; Belinda Lee; Angela Sobremonte; Pamela Castillo; Neil Hughes; Mustefa Mohammedsaid; Anuja Jhingran; Ann H Klopp; Seungtaek Choi; C David Fuller; Lilie L Lin
Journal:  Pract Radiat Oncol       Date:  2022-03-09

Review 8.  Adaptive Radiation Therapy (ART) Strategies and Technical Considerations: A State of the ART Review From NRG Oncology.

Authors:  Carri K Glide-Hurst; Percy Lee; Adam D Yock; Jeffrey R Olsen; Minsong Cao; Farzan Siddiqui; William Parker; Anthony Doemer; Yi Rong; Amar U Kishan; Stanley H Benedict; X Allen Li; Beth A Erickson; Jason W Sohn; Ying Xiao; Evan Wuthrick
Journal:  Int J Radiat Oncol Biol Phys       Date:  2020-10-24       Impact factor: 7.038

9.  Automatic 3D Monte-Carlo-based secondary dose calculation for online verification of 1.5 T magnetic resonance imaging guided radiotherapy.

Authors:  Marcel Nachbar; David Mönnich; Oliver Dohm; Melissa Friedlein; Daniel Zips; Daniela Thorwarth
Journal:  Phys Imaging Radiat Oncol       Date:  2021-06-21

Review 10.  Optimizing MR-Guided Radiotherapy for Breast Cancer Patients.

Authors:  Maureen L Groot Koerkamp; Jeanine E Vasmel; Nicola S Russell; Simona F Shaitelman; Carmel N Anandadas; Adam Currey; Danny Vesprini; Brian M Keller; Chiara De-Colle; Kathy Han; Lior Z Braunstein; Faisal Mahmood; Ebbe L Lorenzen; Marielle E P Philippens; Helena M Verkooijen; Jan J W Lagendijk; Antonetta C Houweling; H J G Desiree van den Bongard; Anna M Kirby
Journal:  Front Oncol       Date:  2020-07-28       Impact factor: 6.244
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.